Interventions delivered in healthcare settings to promote vaping cessation in children and young people (under the age of 18 years): a scoping review
Open Access
- 30 September 2026
- journal article
- Published by BMJ in Archives of Disease in Childhood
Abstract
Objectives: To identify and map interventions delivered in healthcare settings to promote vaping cessation among children and young people (CYP) under 18 years. Design: Scoping review conducted in accordance with Joanna Briggs Institute (JBI) methodology and reported using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR). The review protocol was preregistered and published in BMJ Open . Data sources: Five electronic databases (MEDLINE, Embase, Web of Science, Cochrane Library, CINAHL), clinical trial registries and grey literature sources were searched from January 2004 to February 2026. Eligibility criteria: Sources reporting cessation interventions for CYP under 18 years who currently vape, delivered by healthcare professionals within clinical or community healthcare settings. All study designs and grey literature were eligible. Results: Eight sources were included: five reporting cessation or treatment interventions and three evaluating screening approaches all conducted in North America. All five cessation interventions used multicomponent approaches combining behavioural and pharmacological elements. Nicotine replacement therapy (NRT) was used in four sources. Quit rates ranged from 16.7% to 37%, with considerable variation in how ‘abstinence’ was defined and measured and limited use of biochemical verification. Uptake of cessation support was consistently low across sources. Vaping-specific language and adapted screening tools consistently improved clinical capture rates. Conclusions: Healthcare-based vaping cessation for under-18s is at an early stage of development. No included study tested a structured multicomponent cessation pathway within routine clinical encounters, and no pharmacotherapy trials have been conducted specifically in under-18s. Adequately powered trials recruiting under-18s, prospective evaluation of clinical pathways and research within different healthcare systems are urgently needed.Keywords
Funding Information
- National Institute for Health and Care Research (ACF-2024-05-002)
This publication has 30 references indexed in Scilit:
- Varenicline for Youth Nicotine Vaping CessationJAMA, 2025
- A YOUTH-FOCUSED, VIRTUAL, E-CIGARETTE CESSATION INTERVENTION COMBINING IN-PERSON CBT WITH INCENTIVESDrug and Alcohol Dependence, 2025
- E‐Cigarette Addiction in Adolescents—How Do We Get Them to Stop?Pediatric Pulmonology, 2024
- Co‐design of digital public health substance use resources: A collaboration between young people and expertsHealth Promotion Journal of Australia, 2024
- Identifying Adolescent Vaping With Screening to Brief Intervention and Brief Screener for Tobacco, Alcohol, and Drugs Screening ToolsJournal of Adolescent Health, 2024
- Treatment of Adolescent e-Cigarette Use: Limitations of Existing Nicotine Use Disorder Treatment and Future Directions for e-Cigarette Use CessationJournal of the American Academy of Child & Adolescent Psychiatry, 2021
- Vaping: Impact of Improving Screening Questioning in Adolescent Population: A Quality Improvement InitiativePediatric Quality & Safety, 2020
- Primary Care Interventions for Prevention and Cessation of Tobacco Use in Children and AdolescentsJAMA, 2020
- Beliefs and Self-reported Practices of Health Care Professionals Regarding Electronic Nicotine Delivery Systems: A Mixed-Methods Systematic Review and SynthesisNicotine & Tobacco Research, 2019
- Healthcare Providers' Beliefs and Attitudes About Electronic Cigarettes and Preventive Counseling for Adolescent PatientsJournal of Adolescent Health, 2014